Partnering with leading innovator TrakCel to support cell and gene therapies
We exist to unlock the potential of ground-breaking therapies for healthier futures
With the integration between OCELLOS and Fusion, we are entering a new phase in therapy ecosystem connectivity.
“This integration will ensure that all those involved in the supply and value chains of cell and gene therapies will be able to be kept up to the minute about the progression of a therapy as well as reimbursement and benefit eligibility, allowing them to schedule treatments and appointments more effectively and sympathetically and keep patients better informed.”
Ravi Nalliah, Chief Product and Strategy Officer, TrakCel
“Through this collaboration with TrakCel, we are able to improve speed-to-therapy and simplify the care coordination process to help deliver an enhanced patient and provider experience.”
Dale Hanna, Director, Cell and Gene Therapies, AmerisourceBergen